Standardization in diagnosis and treatment of thyroid carcinoma

Abstract

CLC Number:

R736.1

YAO Jing, LI Chen, TIAN Wen. Standardization in diagnosis and treatment of thyroid carcinoma[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 467-471.

Figures/Tables1

初始复发危险度分层	TSH控制范围
高危组	<0.1 mU/L
中危组	0.1~0.5 mU/L
低危组	单侧腺叶切除术后：0.5~2.0 mU/L 全甲状腺切除或近全甲状腺切除术，术后血清中测不到Tg的情况下0.5~2.0 mU/L 全甲状腺切除或近全甲状腺切除术，术后血清中测到低水平Tg的情况下0.1~0.5 mU/L

References33

[1]	Zahedi A, Bondaz L, Rajaraman M, et al. Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation[J]. Thyroid, 2020, 30(6):871-877
[2]	田文. 甲状腺癌诊治之中国经验与未来走向[J]. 临床外科杂志, 2020, 28(3):201-204.
[3]	中华医学会内分泌学分会, 中华医学会外科学分会, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中国肿瘤临床, 2012, 39(17):1249-1272.
[4]	孙辉, 刘晓莉. 甲状腺癌规范化诊治理念更新及其意义[J]. 中华实用外科杂志, 2015, 30(1):72-75.
[5]	王宇, 田文, 嵇庆海, 等. 甲状腺髓样癌诊断与治疗中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(9):1012-1020.
[6]	石岚, 程波, 屈新才, 等. 甲状腺手术中喉返神经损伤原因及预防[J]. 中国实用外科杂志, 2007, 27(11):897-899.
[7]	Barczyński M, Randolph GW, Cernea CR, et al. External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement[J]. Laryngoscope, 2013, 123(Suppl 4):S1-S14.
[8]	Barczyński M, Konturek A, Stopa M, et al. Randomized controlled trial of visualization versus neuromonitoring of the external branch of the superior laryngeal nerve during thyroidectomy[J]. World J Surg, 2012, 36(6):1340-1347.
[9]	Ravikumar K, Sadacharan D, Muthukumar S, et al. EBSLN and factors influencing its identification and its safety in patients undergoing total thyroidectomy: a study of 456 cases[J]. World J Surg, 2016, 40(3):545-550.
[10]	中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版)[J]. 中国实用外科杂志, 2013, 3(6):470-474.
[11]	Sun H, Tian W, Jiang K, et al. Clinical guidelines on intraoperative neuromonitoring during thyroid and parathyroid surgery[J]. Ann Transl Med, 2015, 3(15):213.
[12]	中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识(2017版)[J]. 中国实用外科杂志, 2017, 37(11):1243-1249.
[13]	中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识[J]. 中国实用外科杂志, 2015, 35(7):731-736.
[14]	陈志达, 郗洪庆, 刘培发, 等. 近红外自体荧光显像技术在甲状腺肿瘤手术中辅助识别甲状旁腺有效性分析[J]. 中国实用外科杂志, 2021, 41(8):882-885.
[15]	杨周, 黄仁宏, 余伟平, 等. 术中甲状旁腺定位技术研究进展[J]. 中国普通外科杂志, 2019, 28(5):612-617.
[16]	Ladurner R, Al Arabi N, Guendogar U, et al. Near-infrared autofluorescence imaging to detect parathyroid glands in thyroid surgery[J]. Ann R Coll Surg Engl, 2018, 100(1):33-36.
[17]	Zhu J, Tian W, Xu Z, et al. Expert consensus statement on parathyroid protection in thyroidectomy[J]. Ann Transl Med, 2015, 3(16):230.
[18]	田文, 费阳, 郗洪庆. 甲状腺手术中新技术的合理应用及展望[J]. 中国实用外科杂志, 2018, 6(38):600-604.
[19]	中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌术后管理中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(9):1021-1028.
[20]	唐润薇. 抑制剂量的甲状腺激素对40例分化型甲状腺癌患者骨化和骨密度的影响[J]. 药物评价研究, 2016, 39(5):814-817.
[21]	Sun B, Hu C, Yang Z, et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells[J]. Oncotarget, 2017, 8(20):32523-32535.
[22]	任崧, 马轶明. 分化型甲状腺癌全切除术后应用甲状腺激素联合¹³¹I治疗疗效及对患者血清球蛋白的影响[J]. 临床医药实践, 2016, 25(3):171-173.
[23]	李亮, 牛高华, 邱福轩, 等. 促甲状腺激素抑制治疗对分化型甲状腺癌术后的疗效及安全性[J]. 实用癌症杂志, 2019, 34(4):587-589.
[24]	刘延晴, 林岩松. 碘难治性分化型甲状腺癌诊治策略及预后[J]. 中国实用外科杂志, 2019, 39(3):216-220.
[25]	丛慧, 梁军, 林岩松. 碘难治性分化型甲状腺癌的诊断与靶向治疗[J]. 国际放射医学核医学杂志, 2015, 39(1):25-31.
[26]	中国临床肿瘤学会CSCO甲状腺癌专家委员会, 中国研究型医院学会甲状腺疾病专业委员会, 中国医师协会外科医师分会甲状腺外科医师委员会, 等. 碘难治性分化型甲状腺癌的诊治管理共识(2019年版)[J]. 中国癌症杂志, 2019, 29(6):476-480.
[27]	Shi X, Yu PC, Lei BW, et al. Association between programmed death-ligand 1 expression and clinicopathological characteristics, structural recurrence, and biochemical recurrence/persistent disease in medullary thyroid carcinoma[J]. Thyroid, 2019, 29(9):1269-1278
[28]	田文, 郗洪庆. 重视甲状腺癌多学科综合治疗[J]. 中国实用外科杂志, 2019, 39(3):197-199.
[29]	管小青, 郑向欣, 顾书成, 等. 多学科团队在晚期特殊类型甲状腺癌诊治中的应用价值[J]. 中国普外基础与临床杂志, 2018, 25(9):1115-1120.
[30]	高博, 田武国, 姜燕, 等. 多学科协作模式在复杂疑难甲状腺肿瘤诊治中的应用[J]. 中华内分泌外科杂志, 2017, 11(4):278-282.
[31]	邓先兆, 孙滨, 康杰, 等. 甲状腺疾病诊治中心在晚期甲状腺癌多学科联合诊治中的作用[J]. 中华内分泌外科杂志, 2017, 11(4):272-273.
[32]	王朝晖, 陈锦, 张可贤, 等. 多学科诊疗模式在局部晚期分化型甲状腺癌中的应用[J]. 临床外科杂志, 2017, 25(11):815-817.
[33]	Shaha AR, Tuttle RM. Commentary: re-recurrence after surgical management of recurrent thyroid cancer[J]. Surgery, 2021, 169(4):844-845.

Standardization in diagnosis and treatment of thyroid carcinoma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables1

References33

Related Articles15

Recommended Articles

Metrics

Comments

[1]	HE Wen, GU Jianhua, XING Xujian, WENG Ziyi, FEI Jian.Tracheal diverticula discovered during surgery: a report of 2 cases and literature review[J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 383-387.
[2]	KONG Weiqi, HE Jun, YANG Chengguang, LIU Weiwei, XU Yingjie.Pheochromocytoma with papillary thyroid carcinoma: one case report[J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 162-165.
[3]	YAN Haibo, XIA Zhongping, CHEN Shan, JIANG Lin, HAN Chun.Risk factors for Delphian lymph node metastasis in papillary thyroid carcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 453-457.
[4]	LI Rui, LIU Zhuoran, YAN Jiqi.Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass[J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 271-275.
[5]	CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben.Diagnosis and treatment of medullary thyroid carcinoma-an update[J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 276-280.
[6]	WU Chunxiao, GU Kai, PANG Yi, BAO Pingping, WANG Chunfang, SHI Liang, XIANG Yongmei, GONG Yangming, DOU Jianming, WU Mengyin, FU Chen, SHI Yan.Thyroid cancer incidence and mortality in Shanghai China 2016 and trends from 2002 to 2016[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 58-65.
[7]	LIU Rongyao, LI Xiangcui, WANG Lina, CHEN Haizhen.Analysis of risk factors for cervical lymph node metastasis in papillary thyroid carcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 76-79.
[8]	.[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 564-567.
[9]	FAN Jinfang, SHEN Yi, ZHAN Weiwei, TAO Lingling, LI Weiwei, KUANG Lijun, ZHOU Wei.Clinicopathological analysis of papillary thyroid microcarcinoma in isthmus[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 528-531.
[10]	ZHANG Gang, ZHANG Zhe, ZHANG Shu, LI Zhirong, TIAN Wuguo, HUANG Qi, WANG Lingli, XU Yan.Association between RET genotype and disease phenotype in patients with hereditary medullary thyroid carcinoma[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 522-527.
[11]	SUN Hanxing, SHEN Xiaohui, GAO Haoji, LIU Zhuoran, CHEN Xi, QIU Weihua, YAN Jiqi.Preoperative evaluation and preparation of Graves′ disease: a report of 126 cases[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 517-521.
[12]	YAN Shouyi, CHEN Hongbin, ZHANG Liyong, WANG Bo, CAI Shaojun, LIN Siying, ZHAO Wenxin.Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 512-516.
[13]	.[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 504-509.
[14]	.[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 497-499.
[15]	.[J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 493-496.